Intera Oncology is committed to changing the treatment options for patients diagnosed with colorectal cancer and cholanqiocarcinoma that has spread to the liver. They offer Hepatic Artery Infusion (HAI) therapy as a powerful treatment option for these conditions. HAI therapy uses the Intera 3000 HAI Pump, which delivers the treatment directly to the liver, providing up to 400 times higher drug concentration to the tumors compared to systemic chemotherapy, while limiting potential side effects.

The therapy is suitable for patients with colorectal cancer that has spread to the liver and intrahepatic cholangiocarcinoma. Founded by family members and friends of patients who benefited from HAI therapy, Intera Oncology's mission is to ensure that this therapy is accessible to all who could benefit from it. The brand is dedicated to providing information and resources for patients and healthcare professionals, with the goal of improving the chances of survival and bettering the quality of life for those diagnosed with these conditions